查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1931184

生物製藥低溫運輸物流服務市場按服務類型、溫度類型、運輸方式、產品類型、包裝類型和最終用途分類，全球預測（2026-2032年）

Biopharmaceutical Cold Chain Logistics Services Market by Service Type, Temperature Type, Mode Of Transportation, Product Type, Packaging Type, End Use - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 182 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，生物製藥低溫運輸物流服務市場規模將達到 59.2 億美元，到 2026 年將成長至 65.2 億美元，到 2032 年將達到 126.2 億美元，年複合成長率為 11.41%。

關鍵市場統計數據
基準年 2025 59.2億美元
預計年份：2026年 65.2億美元
預測年份 2032 126.2億美元
複合年成長率 (%) 11.41%

本文從策略角度概述了溫度敏感型供應鏈如何演變為影響臨床、監管和商業性結果的關鍵系統。

生物製藥低溫運輸物流環境是溫度敏感型治療藥物交付和商業化的關鍵因素。從早期臨床試驗產品的運輸到生物製劑、細胞和基因療法的商業分銷，各機構必須兼顧臨床需求、監管要求和營運限制，以確保產品完整性。這促使物流供應商、臨床試驗申辦者和生產者重新思考傳統模式，並投資於能夠擴大規模同時降低風險的能力。

技術日趨成熟、有效載荷日益複雜以及合規性要求不斷提高，將把低溫運輸物流重塑為一個可預測的、數據驅動的配送生態系統。

低溫運輸物流正經歷一場變革，其驅動力包括技術成熟、監管日益嚴格、溫控產品日益複雜。先進的主動包裝解決方案和嚴密的監控技術能夠實現持續、高精度的遙測，從而在運輸過程中進行主動干預。隨著這些功能逐漸成為標準配置，整個生態系統正從被動的異常管理轉向基於數據分析的預測性調整，從而實現路線最佳化、應急計畫制定和包裝選擇。

政策主導的供應鏈中斷和策略採購應對措施凸顯了關稅變化對溫控物流的具體營運影響。

2025年關稅和貿易政策變化帶來的累積影響將為在國際航線上運營的低溫運輸物流相關人員帶來顯著的成本和營運複雜性。關稅調整將影響進口包裝材料、專用冷凍設備甚至外包服務模組的成本基礎，促使供應鏈重新設計和供應商多元化。因此，進口商和服務供應商需要重新審視採購契約，評估國內採購方案，並權衡對本地資產的資本投資與繼續依賴跨境供應商之間的利弊。

全面的細分分析揭示了相互依存的服務、產品和營運要素，這些要素決定了包裝、運輸和監管策略。

細緻的細分框架揭示了服務產品和產品特性如何影響低溫運輸系統的營運優先順序、合約條款和投資需求。根據服務類型，細分領域涵蓋包裝和監控、法規遵循、倉儲和運輸。在包裝和監控領域，主動包裝和被動包裝在範圍上存在根本差異，資料登錄、監控和追蹤以及被動解決方案都需要不同的檢驗途徑。主動包裝進一步分為冷藏貨櫃和溫控車輛，兩者都需要考慮生命週期管理和能源採購。同時，被動包裝分為乾冰和保溫箱，兩者各自有其獨特的處理、補充和危險物品管理方式。法規遵從服務包括審核、GDP合規性和溫度測繪，為連接營運實務和合規要求奠定了至關重要的基礎。

區域趨勢和基礎設施差異將決定全球溫控網路中包裝、監控和最後一公里配送能力的投資方向。

區域趨勢將對美洲、歐洲、中東和非洲以及亞太地區的低溫運輸物流能力部署和投資重點產生重大影響。在美洲，密集的商業走廊、成熟的臨床試驗網路以及接近性製造地優勢，正在推動快速響應配送模式和主動包裝系統的應用。此外，人們越來越關注用於支持先進治療方法的超低溫解決方案，這促使對專用基礎設施和「最後一公里」配送能力進行投資。

透過整合包裝、檢驗的監測和專業知識，為高價值生技藥品和複雜的臨床價值鏈提供競爭優勢。

低溫運輸物流領域的主要企業透過技術創新、服務整合以及針對高價值、溫度敏感貨物的專業能力實現差異化競爭。領先的服務供應商強調其檢驗的包裝組合，包括主動冷藏集裝箱和最佳化的被動式解決方案，並輔以即時資料登錄和監控系統。這些公司通常整合倉儲和運輸能力，以減少交接環節並降低溫度波動風險，同時也將GDP合規性和溫度測繪等監管服務納入其商業合約中。

透過技術、管治和策略採購選擇，提升溫控供應鏈韌性與合規性的實用藍圖

產業領導者應制定切實可行的藍圖，以確保其溫控供應鏈的安全，在降低即時營運風險與長期策略投資之間取得平衡。首先，優先採用可互通的監控平台，產生持續、審核的遙測數據，並支援自動化升級工作流程。這將縮短決策時間，加快偏差反應速度，並建立可用於指導包裝選擇和運輸方式決策的資料集。其次，加快關鍵包裝組件和檢驗組件的多通路採購，同時對區域供應商進行資格認證，以降低關稅影響並緩解物流瓶頸。

一項採用穩健的混合方法的研究，結合了高階主管訪談、監管分析和橫斷面細分映射，以檢驗可操作的低溫運輸洞察。

本研究整合了一手和二手調查方法，旨在深入了解低溫運輸物流實踐和策略挑戰。一手研究包括對供應鏈主管、品質保證人員、包裝工程師和物流營運經理進行結構化訪談，以了解實際營運挑戰、檢驗方法和投資重點。這些訪談內容與二手資訊相結合，包括監管指導文件、行業最佳實踐框架、包裝和監控技術方面的技術白皮書以及上市公司披露資訊，從而全面了解冷鏈物流的能力和市場動態。

將建構基於整合、敏捷和品質管治的彈性溫控供應鏈網路這一戰略要務納入考量。

這項結論綜合分析了影響溫敏性治療藥物低溫運輸物流的技術、監管和商業性趨勢的策略意義。隨著生物製藥、細胞和基因療法以及全球疫苗接種計畫的普及，市場複雜性日益增加，企業再也不能依賴分散的物流模式。相反，企業需要透過整合檢驗的包裝、持續監控和符合監管要求的流程的服務模式來增強韌性，從而確保產品從原產地到患者的完整性。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 生物製藥低溫運輸物流服務市場（依服務類型分類）

  • 包裝和監測
    • 活性包裝
      • 冷藏貨櫃
      • 溫控車輛
    • 資料登錄
    • 監測與追蹤
    • 被動式封裝
      • 乾冰
      • 保溫箱
  • 監管
    • 審核
    • GDP合規性
    • 溫度分佈圖
  • 貯存
  • 運輸

第9章：依溫度類型分類的生物製藥低溫運輸物流服務市場

  • 冷凍
  • 冷藏
  • 超低溫

第10章 生物製藥低溫運輸物流服務市場（依交通途徑）

  • 空運
  • 鐵路
  • 道路運輸
  • 海上運輸

第11章 生物製藥低溫運輸物流服務市場（依產品類型分類）

  • 細胞和基因治療
  • 單株抗體
  • 治療性蛋白質
  • 疫苗

第12章：依包裝類型分類的生物製藥低溫運輸物流服務市場

  • 活動類型
  • 被動的

第13章 生技製藥低溫運輸物流服務市場（依最終用途分類）

  • 生物製藥
  • 臨床試驗
  • 製藥
  • 疫苗

第14章 生物製藥低溫運輸物流服務市場（依地區分類）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第15章 生物製藥低溫運輸物流服務市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第16章 各國生物製藥低溫運輸物流服務市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第17章：美國生物製藥低溫運輸物流服務市場

第18章：中國生物製藥低溫運輸物流服務市場

第19章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • American Airlines Cargo
  • Biocair International Ltd.
  • Cathay Pacific Cargo
  • Cold Chain Technologies, LLC
  • Cryoport, Inc.
  • CSafe Global
  • Envirotainer AB
  • FedEx Corporation
  • KOR Cooler Inc.
  • Kuehne+Nagel International AG
  • LAN Cargo SA
  • LifeConEx LLC
  • Nordic Cold Storage Solutions
  • Pelican BioThermal LLC
  • Singapore Airlines Cargo
  • SkyCell AG
  • Softbox Systems Ltd.
  • Sonoco ThermoSafe
  • United Parcel Service, Inc.
Product Code: MRR-7B550E008DA4

The Biopharmaceutical Cold Chain Logistics Services Market was valued at USD 5.92 billion in 2025 and is projected to grow to USD 6.52 billion in 2026, with a CAGR of 11.41%, reaching USD 12.62 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 5.92 billion
Estimated Year [2026] USD 6.52 billion
Forecast Year [2032] USD 12.62 billion
CAGR (%) 11.41%

Strategic framing of how temperature-sensitive supply chains have evolved into mission-critical systems shaping clinical, regulatory, and commercial outcomes

The biopharmaceutical cold chain logistics landscape has become a defining factor in the delivery and commercialization of temperature-sensitive therapies. From the earliest clinical trial shipments to commercial distribution of biologics and cell and gene therapies, organizations must reconcile clinical imperatives, regulatory expectations, and operational constraints to protect product integrity. In this context, logistics providers, clinical sponsors, and manufacturers alike are rethinking legacy models and investing in capabilities that reduce risk exposure while enabling scale.

Transitioning from tactical temperature control solutions to vertically integrated, data-rich ecosystems is no longer optional for competitive players. Stakeholders increasingly prioritize end-to-end visibility, validated packaging systems, and regulatory-aligned processes that minimize variability across handoffs. This introduction outlines the drivers that have elevated cold chain logistics from a support function to a strategic differentiator, and sets the stage for deeper analysis of transformative shifts, policy impacts, segmentation nuances, and regional dynamics.

Moving forward, the market will be shaped by the convergence of advanced packaging materials, IoT-enabled monitoring, and a regulatory environment that demands demonstrable chain-of-custody controls. These forces are redefining how product safety, speed-to-market, and cost-efficiency are balanced. The introduction therefore frames the conversation around resilience, compliance, and the operational investments required to meet the needs of next-generation therapeutics.

How technological maturation, payload complexity, and integrated compliance are reshaping cold chain logistics into predictive, data-driven delivery ecosystems

Cold chain logistics is undergoing transformative shifts driven by technological maturation, rising regulatory scrutiny, and the increasing complexity of temperature-sensitive products. Advanced active packaging solutions and rigorous monitoring technologies now provide continuous, high-fidelity telemetry that enables proactive intervention during transit. As these capabilities become standard, the ecosystem is shifting from reactive exception management toward predictive orchestration, where data analytics inform route optimization, contingency planning, and packaging selection.

Concurrently, the nature of payloads is shifting. Cell and gene therapies and personalized medicine introduce variability in vial sizes, dose volumes, and handling instructions, which in turn require bespoke packaging and more frequent controlled-environment transfers. This trend compels logistics providers and sponsors to enhance validation protocols, cold chain qualification exercises, and training programs for handling personnel. In addition, the rise of ultralow temperature therapeutics demands an expanded repertoire of passive and active containment technologies and contingency strategies for long-distance transport.

Another critical shift is the integration of regulatory and quality functions within logistics operations. Temperature mapping, GDP compliance, and auditing are no longer perfunctory checkboxes; they are embedded into contractual service level agreements and performance dashboards. Collaboration between QA/QC teams and logistics operators has intensified, with joint ownership of deviation investigation, root cause analysis, and CAPA implementation. Finally, strategic partnerships and service consolidation are changing the competitive landscape. End users increasingly prefer single-source providers capable of packaging, monitoring, storage, and transport across multiple temperature regimes, reducing handoff risk and streamlining accountability.

Policy-driven supply chain disruption and strategic procurement responses highlighting the tangible operational effects of tariff shifts on temperature-controlled logistics

The cumulative impact of tariffs and trade policy changes in 2025 introduces a material layer of cost and operational complexity for cold chain logistics stakeholders who operate across international corridors. Tariff adjustments can affect the cost basis for imported packaging components, specialized refrigeration equipment, and even outsourced service modules, prompting supply chain redesigns and supplier diversification. Importers and service providers must therefore revisit procurement contracts, evaluate domestic sourcing alternatives, and assess the trade-offs between capital investment in localized assets and continued reliance on cross-border suppliers.

Beyond direct cost implications, tariffs can influence mode selection and routing decisions. Air freight may become less predictable as carriers adjust capacity and pricing strategies; consequently, organizations may accelerate investment in modal flexibility that includes rail and sea alternatives with appropriate temperature control solutions. Where duties change the economics of certain packaging materials or components, the industry may see a shift toward modular design and component standardization that permits local substitution without triggering regulatory requalification.

In parallel, tariff-driven uncertainty increases the value of real-time visibility and scenario modeling. Logistics teams must incorporate tariff scenarios into total landed cost analyses and evaluate the regulatory implications of changing suppliers, particularly for validated components used in GMP environments. To manage risk, stakeholders should prioritize agility in supplier qualification, expand multi-sourcing strategies, and build cross-functional governance that aligns procurement, quality, and logistics decision-making under varying trade regimes. Ultimately, the 2025 tariffs underscore the importance of supply chain resilience and proactive policy monitoring to maintain uninterrupted delivery of temperature-sensitive therapies.

Comprehensive segmentation analysis revealing interdependent service, product, and operational vectors that determine packaging, transport, and regulatory strategies

A nuanced segmentation framework reveals how service offerings and product characteristics shape operational priorities, contractual terms, and investment needs across the cold chain ecosystem. Based on Service Type, the landscape spans Packaging & Monitoring, Regulatory, Storage, and Transport; within Packaging & Monitoring, Active Packaging and Passive Packaging differ fundamentally in operational scope, while Data Logging, Monitoring & Tracking, and Passive solutions require distinct validation pathways. Active Packaging further divides into Refrigerated Containers and Temperature Controlled Vehicles, each demanding lifecycle management and energy sourcing considerations, while Passive Packaging branches into Dry Ice and Insulated Boxes, which carry unique handling, replenishment, and hazardous material controls. Regulatory services encompass Auditing, GDP Compliance, and Temperature Mapping and form an essential overlay that binds operational practice to compliance expectations.

Looking at Temperature Type, Frozen, Refrigerated, and Ultralow regimes impose divergent requirements for containment design, transit duration, and storage infrastructure. Each temperature band affects choice of packaging, monitoring thresholds, and contingency planning. When examined through Mode Of Transportation, differences among Air, Rail, Road, and Sea create variability in transit time, exposure risk, and regulatory touchpoints, and these modal choices interplay with payload characteristics and destination geography.

End Use segmentation shows the distinct expectations of Biologics, Clinical Trials, Pharmaceuticals, and Vaccines, where clinical supply chains emphasize lot integrity and traceability, and commercial distributions emphasize throughput and cost efficiency. Product Type segmentation, including Cell And Gene Therapies, Monoclonal Antibodies, Therapeutic Proteins, and Vaccines, highlights how product stability and delivery modality influence packaging selection and handling protocols. Packaging Type reiterates the Active versus Passive dichotomy with the same Refrigerated Containers, Temperature Controlled Vehicles, Dry Ice, and Insulated Boxes considerations, while Logistics Function segmentation-Inbound, Outbound, and Reverse, with Reverse including Disposal Services and Returns Management-draws attention to lifecycle management and end-of-life handling. Finally, End User segmentation across Contract Logistics Providers, Contract Research Organizations, Pharma Companies, and Research Institutes underscores the differing contractual frameworks, service level expectations, and investment appetites that define customer-provider relationships in the cold chain space.

Synthesizing these segmentation lenses clarifies that decision-making is multivariate: packaging choice is inseparable from temperature type and mode of transport; regulatory services are integral to every segment; and end users vary in their tolerance for operational risk, service consolidation, and capital intensity. Therefore, strategic planning must align across segmentation dimensions to ensure coherence between technical capabilities and commercial commitments.

Regional dynamics and infrastructure disparities that determine where to invest in packaging, monitoring, and last-mile capabilities across global temperature-controlled networks

Regional dynamics materially influence how cold chain logistics capabilities are deployed and how investments are prioritized across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, dense commercial routes, established clinical trial networks, and proximity to manufacturing hubs favor rapid-response distribution models and significant adoption of active packaging systems. This region also shows a growing emphasis on ultralow temperature solutions to support advanced therapies, which in turn drives investments in specialized infrastructure and last-mile capabilities.

In Europe, Middle East & Africa, regulatory harmonization efforts and cross-border trade complexities encourage a strong focus on GDP compliance, temperature mapping, and audited storage solutions. The EMEA region features a diverse set of infrastructure capabilities, where mature Western European markets often push for high-touch service integration while certain emerging markets require targeted investments to standardize handling and monitoring practices. Regulatory convergence and the need for validated cross-border transit corridors make collaboration among logistics providers, regulators, and manufacturers particularly important.

Asia-Pacific presents a unique combination of rapid demand growth, manufacturing scale-up, and logistical diversity. The region's heterogeneity necessitates flexible mode-of-transport strategies that integrate air, sea, and road solutions while accommodating variable cold storage capabilities at origin and destination points. Public sector investments in healthcare infrastructure and the expansion of regional distribution hubs are accelerating adoption of both passive and active packaging technologies, especially where domestic production of biologics and vaccines is increasing. Across all regions, the interplay between infrastructure maturity, regulatory frameworks, and demand profiles informs where to locate assets, which partnerships to pursue, and how to prioritize investments in monitoring, packaging, and staffing.

Competitive differentiation through integrated packaging, validated monitoring, and specialized capabilities that support high-value biologics and complex clinical supply chains

Key companies operating within cold chain logistics are differentiating through a combination of technological innovation, service integration, and specialized capabilities tailored to high-value, temperature-sensitive payloads. Leading service providers emphasize validated packaging portfolios that include both active refrigerated containers and optimized passive solutions, supported by real-time data logging and monitoring systems. These firms typically combine storage and transport capabilities to reduce handoffs and limit exposure to temperature excursions, while embedding regulatory services such as GDP compliance and temperature mapping into commercial agreements.

Other notable players specialize in niche capabilities such as ultralow temperature storage, clinical trial logistics, or reverse logistics for returns and disposal services. These companies often partner with device manufacturers, packagers, and local carriers to expand geographic reach without diluting technical control. Strategic differentiation also comes through digital platforms that provide end-to-end visibility, predictive alerts, and analytics to demonstrate chain-of-custody and support deviation investigations. Investment in personnel training, accredited auditing teams, and quality systems reinforces commercial credibility, particularly for customers handling cell and gene therapies or large-scale vaccine programs.

Across the competitive landscape, alliances between packaging innovators, monitoring technology vendors, and logistics operators are becoming more common as stakeholders pursue integrated offers that simplify procurement and provide single-vendor accountability. For buyers, the selection criteria increasingly emphasize not only cost and capacity but also validation history, incident response capabilities, and the ability to scale services to meet evolving product and market complexity.

Actionable roadmap for strengthening resilience and compliance in temperature-controlled supply chains through technology, governance, and strategic sourcing choices

Industry leaders should adopt a pragmatic roadmap that balances immediate operational risk reduction with longer-term strategic investments to secure temperature-controlled supply chains. First, prioritize deployment of interoperable monitoring platforms that generate continuous, auditable telemetry and support automated escalation workflows. This will reduce dwell time in decision-making, accelerate deviation resolution, and create datasets that inform packaging selection and modal decisions. Second, accelerate multi-sourcing of critical packaging components and validated assemblies while qualifying regional suppliers to reduce tariff sensitivity and logistics bottlenecks.

Third, invest in training programs and joint governance structures that align quality, procurement, and logistics functions under unified SOPs and KPI frameworks. This cross-functional alignment ensures that regulatory compliance drives operational decisions and that deviations trigger coordinated CAPA initiatives rather than siloed investigations. Fourth, evaluate the business case for localized ultralow and refrigerated infrastructure in high-demand markets to reduce time-in-transit risk and improve responsiveness for advanced therapies. Fifth, pursue commercial models that bundle packaging, monitoring, storage, and transport to limit handoffs and create single points of accountability, while negotiating clear SLAs and performance penalties for temperature excursions.

Finally, embrace scenario planning that incorporates tariff fluctuations, modal disruptions, and regulatory changes to inform contingency playbooks. By stress-testing network design and running tabletop exercises, leaders can validate redundancy, clarify escalation paths, and ensure that contractual mechanisms support rapid response. Together, these actions will reduce product risk exposure, enhance regulatory readiness, and create operational agility necessary for the next generation of biologics and personalized therapies.

Robust mixed-methods research design combining executive interviews, regulatory analysis, and cross-sectional segmentation mapping to validate actionable cold chain insights

This research integrates primary and secondary data collection methodologies to produce evidence-based insights into cold chain logistics practices and strategic imperatives. Primary research included structured interviews with supply chain executives, quality assurance leaders, packaging engineers, and logistics operations managers to capture frontline operational challenges, validation approaches, and investment priorities. These conversations were synthesized with secondary sources such as regulatory guidance documents, industry best-practice frameworks, technical white papers on packaging and monitoring technologies, and publicly available corporate disclosures to construct a holistic view of capabilities and market dynamics.

The analytical approach involved cross-sectional segmentation mapping to identify how service types, temperature regimes, modes of transport, and end-use cases interact to shape operational requirements. Case studies were developed to illustrate successful integration of active and passive packaging strategies, regulatory compliance programs, and multimodal routing. Data triangulation ensured that qualitative findings were corroborated by documented protocol standards and technology specifications. Wherever possible, validation steps included follow-up interviews and peer review from subject matter experts to confirm accuracy and applicability of conclusions.

Limitations are acknowledged, particularly where proprietary commercial arrangements or novel proprietary technologies limit disclosure. To mitigate this, the methodology emphasizes pattern recognition across multiple independent sources and prioritizes examples that demonstrate replicable practices. The resulting methodology provides a robust foundation for the report's strategic recommendations and regionally informed insights, while offering transparency about data provenance and analytical assumptions.

Synthesis of strategic imperatives emphasizing integration, agility, and quality governance as the foundation for resilient temperature-controlled supply networks

The conclusion synthesizes the strategic implications of technological, regulatory, and commercial trends shaping cold chain logistics for temperature-sensitive therapies. As market complexity intensifies with the proliferation of biologics, cell and gene therapies, and global vaccination programs, organizations can no longer rely on siloed logistics practices. Instead, resilience will be delivered through integrated service models that combine validated packaging, continuous monitoring, and regulatory-aligned processes to ensure product integrity from origin to patient.

Moreover, the dual pressures of policy change and evolving payload characteristics demand proactive supply chain design. Firms that invest early in interoperable data platforms, multi-sourced validated components, and localized infrastructure where appropriate will be better positioned to absorb shocks, adapt to tariff and modal shifts, and support rapid scale-up for clinical and commercial launches. Collaboration across industry participants-including shippers, packagers, carriers, and regulatory stakeholders-will accelerate standardization and reduce friction at international handoffs. Ultimately, the strategic winners will be those who treat cold chain logistics as a core competency, embedding quality and agility into every tier of their distribution networks to protect product value and patient safety.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biopharmaceutical Cold Chain Logistics Services Market, by Service Type

  • 8.1. Packaging & Monitoring
    • 8.1.1. Active Packaging
      • 8.1.1.1. Refrigerated Containers
      • 8.1.1.2. Temperature Controlled Vehicles
    • 8.1.2. Data Logging
    • 8.1.3. Monitoring & Tracking
    • 8.1.4. Passive Packaging
      • 8.1.4.1. Dry Ice
      • 8.1.4.2. Insulated Boxes
  • 8.2. Regulatory
    • 8.2.1. Auditing
    • 8.2.2. GDP Compliance
    • 8.2.3. Temperature Mapping
  • 8.3. Storage
  • 8.4. Transport

9. Biopharmaceutical Cold Chain Logistics Services Market, by Temperature Type

  • 9.1. Frozen
  • 9.2. Refrigerated
  • 9.3. Ultralow

10. Biopharmaceutical Cold Chain Logistics Services Market, by Mode Of Transportation

  • 10.1. Air
  • 10.2. Rail
  • 10.3. Road
  • 10.4. Sea

11. Biopharmaceutical Cold Chain Logistics Services Market, by Product Type

  • 11.1. Cell & Gene Therapies
  • 11.2. Monoclonal Antibodies
  • 11.3. Therapeutic Proteins
  • 11.4. Vaccines

12. Biopharmaceutical Cold Chain Logistics Services Market, by Packaging Type

  • 12.1. Active
  • 12.2. Passive

13. Biopharmaceutical Cold Chain Logistics Services Market, by End Use

  • 13.1. Biologics
  • 13.2. Clinical Trials
  • 13.3. Pharmaceuticals
  • 13.4. Vaccines

14. Biopharmaceutical Cold Chain Logistics Services Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Biopharmaceutical Cold Chain Logistics Services Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Biopharmaceutical Cold Chain Logistics Services Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Biopharmaceutical Cold Chain Logistics Services Market

18. China Biopharmaceutical Cold Chain Logistics Services Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. American Airlines Cargo
  • 19.6. Biocair International Ltd.
  • 19.7. Cathay Pacific Cargo
  • 19.8. Cold Chain Technologies, LLC
  • 19.9. Cryoport, Inc.
  • 19.10. CSafe Global
  • 19.11. Envirotainer AB
  • 19.12. FedEx Corporation
  • 19.13. KOR Cooler Inc.
  • 19.14. Kuehne + Nagel International AG
  • 19.15. LAN Cargo S.A.
  • 19.16. LifeConEx LLC
  • 19.17. Nordic Cold Storage Solutions
  • 19.18. Pelican BioThermal LLC
  • 19.19. Singapore Airlines Cargo
  • 19.20. SkyCell AG
  • 19.21. Softbox Systems Ltd.
  • 19.22. Sonoco ThermoSafe
  • 19.23. United Parcel Service, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED CONTAINERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED CONTAINERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED CONTAINERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE CONTROLLED VEHICLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE CONTROLLED VEHICLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE CONTROLLED VEHICLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DATA LOGGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DATA LOGGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DATA LOGGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONITORING & TRACKING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONITORING & TRACKING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONITORING & TRACKING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DRY ICE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DRY ICE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY DRY ICE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY INSULATED BOXES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY INSULATED BOXES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY INSULATED BOXES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AUDITING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AUDITING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AUDITING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GDP COMPLIANCE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GDP COMPLIANCE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GDP COMPLIANCE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE MAPPING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE MAPPING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE MAPPING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY STORAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY STORAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY FROZEN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY FROZEN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY FROZEN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REFRIGERATED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ULTRALOW, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ULTRALOW, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ULTRALOW, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY AIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY RAIL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY RAIL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY RAIL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ROAD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ROAD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ROAD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SEA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SEA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SEA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CELL & GENE THERAPIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CELL & GENE THERAPIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CELL & GENE THERAPIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY THERAPEUTIC PROTEINS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY THERAPEUTIC PROTEINS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY THERAPEUTIC PROTEINS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY BIOLOGICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY BIOLOGICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY BIOLOGICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY CLINICAL TRIALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY VACCINES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 117. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 118. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. AMERICAS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 164. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 167. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 168. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 169. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 170. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 172. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 175. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 177. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 178. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 179. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 180. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 181. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 182. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 183. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. AFRICA BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 186. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 189. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 190. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 191. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 192. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 193. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 194. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. ASIA-PACIFIC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 198. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 199. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 200. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 201. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 202. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 203. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 204. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 206. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 208. ASEAN BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 209. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 210. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 212. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 213. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 214. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 215. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 217. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 219. GCC BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 220. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 222. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 223. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 224. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 225. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 226. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 227. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 228. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 229. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 230. EUROPEAN UNION BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 231. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 232. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 234. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 235. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 236. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 237. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 239. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 241. BRICS BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 242. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 245. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 246. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 247. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2018-2032 (USD MILLION)
  • TABLE 248. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY TEMPERATURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 249. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY MODE OF TRANSPORTATION, 2018-2032 (USD MILLION)
  • TABLE 250. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING TYPE, 2018-2032 (USD MILLION)
  • TABLE 252. G7 BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 253. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY SERVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 255. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PACKAGING & MONITORING, 2018-2032 (USD MILLION)
  • TABLE 256. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY ACTIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 257. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY PASSIVE PACKAGING, 2018-2032 (USD MILLION)
  • TABLE 258. NATO BIOPHARMACEUTICAL COLD CHAIN LOGISTICS SERVICES MARKET SIZE, BY REGULATORY, 2